AlternativeMed
Symptoms Conditions Remedies Herbs Ingredients Medications Genes
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
Subject Type: 🌿 Herbs ⚗️ Ingredients 📜 Formulas 🧬 Targets 🏥 Diseases
Quick picks: Abetalipoproteinemia Abortion, Habitual Agenesis Acanthamoeba Keratitis Acanthosis Nigricans Achondrogenesis Achondroplasia Acne Vulgaris Acne Keloid Apert Syndrome
🏥 Disease / Health Topic

Metastatic Gastric Adenocarcinoma

Open on HERB 2.0 ↗
3
Clinical Trials
0
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT04220827
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
Active_Not_Recruiting · Phase 1
NCT02539225
A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
Completed · Phase 2
NCT03990103
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites
Unknown · Phase 2
📊 Sample Meta-Analyses
None linked yet.
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Metastatic Gastric Adenocarcinoma
🏥 Names
Disease Name
Metastatic Gastric Adenocarcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
🔗 External References
HERB DB
HBDIS020891 ↗
DisGeNET
C3160888
🔍 Raw view — every non-empty column on this row (19 fields)
name
Metastatic Gastric Adenocarcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
umls disease type id
T191
herb disease id
HBDIS020891
disgenet id
C3160888

⚗️ Related Ingredients

1 · compounds in this herb
Taxol

📋 Clinical Trials

3 · subject of clinical study
NCT04220827 Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
→ Clinical Stage IV Gastric Cancer AJCC v8|Clinical
NCT02539225 A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction
→ Metastatic Gastric Adenocarcinoma|Gastroesophageal
NCT03990103 S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Tr
→ Metastatic Gastric Adenocarcinoma
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables